ATA179380A - Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-athyl-7,13,14trihydroxy-3,5,7,9,12,14-hexa- methyloxacyclopentadecan-2-ons- und dessen derivaten - Google Patents

Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-athyl-7,13,14trihydroxy-3,5,7,9,12,14-hexa- methyloxacyclopentadecan-2-ons- und dessen derivaten

Info

Publication number
ATA179380A
ATA179380A AT0179380A AT179380A ATA179380A AT A179380 A ATA179380 A AT A179380A AT 0179380 A AT0179380 A AT 0179380A AT 179380 A AT179380 A AT 179380A AT A179380 A ATA179380 A AT A179380A
Authority
AT
Austria
Prior art keywords
methyloxacyclopentadecan
desosaminyl
athyl
ons
aza
Prior art date
Application number
AT0179380A
Other languages
English (en)
Other versions
AT369750B (de
Inventor
Gabrijela Mag Kobrehel
Gorjana Mag Radobolja
Zrinka Dr Tamburasev
Slobodan Dr Djokic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of ATA179380A publication Critical patent/ATA179380A/de
Application granted granted Critical
Publication of AT369750B publication Critical patent/AT369750B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0179380A 1979-04-02 1980-04-02 Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-aethyl-7,13,14- AT369750B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU768/79A YU43116B (en) 1979-04-02 1979-04-02 Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox

Publications (2)

Publication Number Publication Date
ATA179380A true ATA179380A (de) 1982-06-15
AT369750B AT369750B (de) 1983-01-25

Family

ID=25551353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0179380A AT369750B (de) 1979-04-02 1980-04-02 Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-aethyl-7,13,14-

Country Status (10)

Country Link
US (1) US4328334A (de)
JP (1) JPS57114598A (de)
AT (1) AT369750B (de)
CA (1) CA1142517A (de)
CH (1) CH646440A5 (de)
DE (2) DE3051049C2 (de)
GB (1) GB2047247B (de)
SI (1) SI7910768A8 (de)
SU (1) SU1093253A3 (de)
YU (1) YU43116B (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
JPS59225198A (ja) * 1983-05-23 1984-12-18 フアイザ−・インコ−ポレ−テツド 抗菌性を有する９―デオキソ―９ａ―アザ―９ａ―ホモエリスロマイシンＡ，その製造方法および組成物
EP0132026B1 (de) * 1983-05-23 1986-12-30 Pfizer Inc. Cyclische Ether, mit antibakterieller Wirkung, von 9-Deoxy-9a-Aza-9a-Homoerythromycin und Zwischenprodukte
US4492688A (en) * 1983-11-25 1985-01-08 Pfizer Inc. Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
US4464527A (en) * 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
SI8311553A8 (en) * 1983-07-18 1995-06-30 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladynosil-12-0-desosaminyl-4,5-dihydroxy-6- ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1.) hexadeca-1(2)-ene-8-ones
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
EP0283055B1 (de) * 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. 10-Dihydro-10-deoxo-11-azaerythronolid-A-Verbindungen,Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung in Arzneimitteln und in deren Herstellung
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5523401A (en) * 1991-04-09 1996-06-04 Abbott Laboratories Macrocyclic lactam prokinetic agents
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
DE69403963T2 (de) * 1993-05-19 1997-11-20 Pfizer Zwischenprodukt für azithromycin
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
US6339063B1 (en) * 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
WO1999012552A1 (en) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
HRP970714B1 (en) * 1997-12-31 2003-08-31 Pliva Pharm & Chem Works Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
HRP990130B1 (en) * 1999-05-03 2004-06-30 Pliva D D HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6764996B1 (en) * 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
EP1101769A3 (de) * 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate
DE60026718T2 (de) 2000-07-25 2006-11-16 Laboratorio Silanes, S.A. De C.V. Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
EP1313749B1 (de) * 2000-08-23 2005-10-12 Wockhardt Limited Verfahren zur herstellung von wasserfreiem azithromycin
ES2179756B1 (es) * 2000-11-30 2004-10-01 Ercros Industrial, S.A. Procedimiento de obtencion de azaeritromicina.
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
MXPA03009786A (es) 2001-04-27 2004-01-29 Pfizer Prod Inc Procedimiento para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-sustituidos.
EA007618B1 (ru) * 2001-05-22 2006-12-29 Пфайзер Продактс Инк. Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
CZ2004232A3 (cs) * 2001-08-21 2005-10-12 Pfizer Products Inc. Jednorázová dávka azithromycinu
US20040186063A1 (en) * 2002-02-15 2004-09-23 Hans-Jurgen Gutke Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1483277A4 (de) 2002-02-15 2007-10-03 Merckle Gmbh Konjugate biologisch aktiver verbindungen, verfahren zu deren herstellung und anwendung, formulierung und pharmazeutische anwendungen davon
AU2003215245A1 (en) * 2002-02-15 2003-09-09 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) * 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
HRP20020779A2 (en) * 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
HRP20020885B1 (en) * 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
HRP20020991A2 (en) * 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
JPWO2005019238A1 (ja) * 2003-08-22 2006-10-19 明治製菓株式会社 新規アザライド及びアザラクタム誘導体とその製造法
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
CN102863486A (zh) * 2012-09-18 2013-01-09 太仓市运通化工厂 一种9-脱氧-9a-氮杂-9a-高红霉素的合成方法
AU2018225389B2 (en) 2017-02-22 2021-09-02 ISR Immune System Regulation Holding AB (publ) Novel immune stimulating compound
EP3585793B1 (de) 2017-02-22 2021-01-06 ISR Immune System Regulation Holding AB (publ) Neuartige immun-stimulierende macrolide
US20230321229A1 (en) 2020-09-03 2023-10-12 ISR Immune System Regulation Holding AB (publ) Vaccine comprising an antigen and a tlr2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US3652537A (en) * 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine

Also Published As

Publication number Publication date
DE3012533C2 (de) 1988-09-29
GB2047247A (en) 1980-11-26
CH646440A5 (de) 1984-11-30
DE3051049C2 (de) 1991-08-22
GB2047247B (en) 1983-05-25
JPS57114598A (en) 1982-07-16
SU1093253A3 (ru) 1984-05-15
YU76879A (en) 1982-10-31
DE3012533A1 (de) 1980-10-16
US4328334A (en) 1982-05-04
AT369750B (de) 1983-01-25
SI7910768A8 (en) 1996-06-30
JPS6364438B2 (de) 1988-12-12
CA1142517A (en) 1983-03-08
YU43116B (en) 1989-04-30

Similar Documents

Publication Publication Date Title
ATA179380A (de) Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-athyl-7,13,14trihydroxy-3,5,7,9,12,14-hexa- methyloxacyclopentadecan-2-ons- und dessen derivaten
AT373893B (de) Verfahren zur herstellung der neuen kristallinen 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amin -alpha-phenylacetamido)-penicillanat-tosylat -hydrate
AT347582B (de) Verfahren zur herstellung des neuen 4'- deoxydaunomycins
AT367011B (de) Verfahren zur herstellung des neuen 1(s), 4(r),
ATA296079A (de) Verfahren zur herstellung des neuen 17alphaethinyl-1,3-dibenzoyloxy-7alpha-methyl-1,3,5(10)oestratrien-17beta-ols
AT373892B (de) Verfahren zur herstellung des neuen kristallinen 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amin
AT365588B (de) Verfahren zur herstellung von neuen spiropyridochroman-4',5-hydantoinen
AT350071B (de) Verfahren zur herstellung des neuen 3,5,5- trimethylhexanoyl-ferrocens
AT358593B (de) Verfahren zur herstellung von neuen 1,2,4- -triazin-5-on-derivaten
AT346361B (de) Verfahren zur herstellung des neuen 1- (2,3- dihydro-2-furyl)-5-fluoruracils
ATA459980A (de) Verfahren zur herstellung des neuen vitam d3derivates 1alpha,25,26-trihydroxycholecalciferol
AT375941B (de) Verfahren zur herstellung von neuen 1-aminopyrazolo (1,5-c) chinazolinderivaten
AT367771B (de) Verfahren zur herstellung des neuen chlormethyl -17alpha-acetoxy-9alpha-fluor-11beta-hydroxy -16beta-methyl-3-oxoandrosta-1,4-dien-17beta -carboxylats
AT366363B (de) Verfahren zur herstellung des neuen alpha-n-acetyl-l-phenylalanyl-l-arginin-aethyles ers
AT361010B (de) Verfahren zur herstellung des neuen 1,6-di-0- methansulfonyl-3,4-di-0-methyl-d-mannits
AT361925B (de) Verfahren zur herstellung des neuen n-6-chlor- nicothinoyl-d,1-homocysteinthiolactons und dessen salzen
ATA501779A (de) Verfahren zur herstellung des neuen 2,4,6-tris- -chlorsulfenyl-s-triazin
AT357562B (de) Verfahren zur herstellung des neuen n-methoxy- carbonyl-n'-trifluormethansulfonylhydrazins
ATA207781A (de) Verfahren zur herstellung von neuen 1,1,2-triphenyl-propen-derivaten
AT367758B (de) Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten
ATA553981A (de) Verfahren zur herstellung des neuen 17beta-n,n-
ATA554081A (de) Verfahren zur herstellung des neuen 17beta-n,n-
ATA350681A (de) Verfahren zur herstellung des neuen chlormethyl-17alpha-acetoxy-9alpha-fluor-11beta hydroxy-16betamethyl-3-oxo-androsta-1,4-dien-17beta-carboxyla s
AT377258B (de) Verfahren zur herstellung von neuen 4-hydroxycumarin- und 1,3-indandion-derivaten
AT352719B (de) Verfahren zur herstellung des neuen 2,6,6- trimethyl-2-cyanmethyl-tetrahydropyrans

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELA Expired due to lapse of time